指南与共识技术与安全CTMRUSPET

多学科建议:疫苗后淋巴结病与影像学检查——Radiology科学专家小组报告

Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel.
指南 / 共识 · Radiology · 2021-02-24

该特别报告由美国三家领先三级癌症中心的多学科专家小组制定,针对COVID-19疫苗接种后淋巴结病在癌症患者中可能与恶性淋巴结受累混淆的问题提出建议。建议常规筛查影像应安排在最终疫苗接种剂量之前或之后至少6周,但不应因接种史延迟有临床指征的影像检查;疫苗应接种于原发或疑似癌症的对侧,两剂均在同一手臂注射;接种信息应纳入影像前问卷并供阅片医生获取。

要点

  • 常规筛查影像应安排在最终疫苗接种剂量之前或之后至少6周,以允许反应性淋巴结病消退。
  • 有临床指征的影像检查(如急性症状、短间隔治疗监测、紧急治疗计划或并发症)不应因既往接种而延迟。
  • 疫苗应接种于原发或疑似癌症的对侧,且两剂均在同一手臂注射;接种信息应便于阅片医生获取。

核心结论

  • 疫苗接种相关淋巴结病是COVID-19疫苗接种后常见的影像学表现,在癌症患者中可能与恶性淋巴结受累难以区分;该多学科专家小组为此提出了影像检查安排和接种侧别的建议。

研究设计与样本

  • 该特别报告由美国三家领先三级癌症中心的多学科专家小组制定,在缺乏研究和循证指南的情况下提供建议。

关键影像表现/征象

  • 疫苗接种相关淋巴结病是COVID-19疫苗接种后常见的影像学表现,在癌症患者中可能与恶性淋巴结受累难以区分。

临床应用与阅片要点

  • 常规影像检查(如筛查)应安排在最终疫苗接种剂量之前或之后至少6周,以允许反应性淋巴结病消退。
  • 有临床指征的影像检查(如急性症状、短间隔治疗监测、紧急治疗计划或并发症)不应因既往接种而延迟。
  • 疫苗应接种于原发或疑似癌症的对侧,两剂均在同一手臂注射。
  • 每次影像前患者问卷应包含接种日期、注射部位、侧别和疫苗类型,且该信息应便于阅片医生获取。
  • 处理COVID-19疫苗接种背景下的淋巴结病时,患者、放射科医生、转诊医师团队和公众之间的清晰有效沟通应被视为最高优先级。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Vaccination-associated adenopathy is a frequent imaging finding after administration of COVID-19 vaccines that may lead to a diagnostic conundrum in patients with manifest or suspected cancer, in whom it may be indistinguishable from malignant nodal involvement. To help the medical community address this concern in the absence of studies and evidence-based guidelines, this special report offers recommendations developed by a multidisciplinary panel of experts from three of the leading tertiary care cancer centers in the United States. According to these recommendations, some routine imaging examinations, such as those for screening, should be scheduled before or at least 6 weeks after the final vaccination dose to allow for any reactive adenopathy to resolve. However, there should be no delay of other clinically indicated imaging (eg, for acute symptoms, short-interval treatment monitoring, urgent treatment planning or complications) due to prior vaccination. The vaccine should be administered on the side contralateral to the primary or suspected cancer, and both doses should be administered in the same arm. Vaccination information-date(s) administered, injection site(s), laterality, and type of vaccine-should be included in every preimaging patient questionnaire, and this information should be made readily available to interpreting radiologists. Clear and effective communication between patients, radiologists, referring physician teams, and the general public should be considered of the highest priority when managing adenopathy in the setting of COVID-19 vaccination.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Becker AS, Perez-Johnston R, Chikarmane SA, et al. Multidisciplinary Recommendations Regarding Post-Vaccine Adenopathy and Radiologic Imaging: Radiology Scientific Expert Panel. Radiology. 2021. PMID: 33625298. doi:10.1148/radiol.2021210436

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。